QuantLogix's 5-factor engine currently reads BlossomHill Therapeutics, Inc. Common Stock (BLSM) as a buy at 65/100 — a bullish setup. Microstructure is the strongest leg at 94/100, while momentum lags at 48/100. BLSM trades in the Pharmaceutical Preparations sector with a $818M market cap.
Updated · recomputed every few minutes while markets are open.
The score blends five independent reads of the stock — technical (trend and chart structure), momentum (rate of change across horizons), fundamental (valuation, growth and quality), options (positioning and implied volatility) and microstructure (order flow and liquidity) — into one number from 0 to 100. The weights adapt to the ticker; the bars above show the live weight of each factor.
| Score | Band |
|---|---|
| 70–100 | Strong Buy |
| 50–69 | Buy |
| 30–49 | Neutral |
| 16–29 | Sell |
| 0–15 | Strong Sell |
BlossomHill Therapeutics, Inc. Common Stock (BLSM) reads Buy at 65 out of 100 on QuantLogix's 5-factor quant signal as of Oct 27, 2026, 9:43 AM ET — a bullish read. Microstructure is the strongest factor at 94/100 and momentum is the weakest at 48/100.
QuantLogix's model currently classifies BLSM as Buy (65/100). That is a quantitative reading of price, momentum, fundamentals, options and order flow — not a personal recommendation. It recomputes every few minutes, so re-check it before acting and weigh your own goals and risk.
The score is a weighted blend of five factors. For BLSM the live weights are technical 46%, momentum 20%, fundamental 4%, microstructure 30%. Scores map to bands: Strong Buy 70–100, Buy 50–69, Neutral 30–49, Sell 16–29, Strong Sell 0–15.
Every QuantLogix signal is logged when it is issued and graded against the live market. Across 6,970 resolved signals the average return is +0.21% per signal. The full, audited record is public at quantlogix.ai/proof.
The signal recomputes every few minutes while markets are open, and this page refreshes within five minutes of each update. It is free to read with no account.
Live 5-factor quant signal — technical, momentum, fundamental, options, and microstructure — recomputed every few minutes. Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. See the verified track record → · Browse all signal scorecards →